P vera
Showing 1 - 25 of 3,799
Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))
Not yet recruiting
- Polycythemia Vera
- Ropeginterferon alfa-2b-njft (P1101)
- (no location specified)
Jul 28, 2022
Polycythemia Vera Trial in Italy
Recruiting
- Polycythemia Vera
-
Reggio Calabria, Calabria, Italy
- +21 more
Nov 10, 2023
Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))
Recruiting
- Polycythemia Vera (PV)
- P1101 (Ropeginterferon alfa-2b)
-
Toon-shi, Ehime, Japan
- +5 more
Jun 13, 2022
Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)
Active, not recruiting
- Polycythemia Vera
- Ropeginterferon alfa-2b
-
Beijing, China
- +13 more
Aug 1, 2022
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera
Completed
- Adherence, Patient
- Adherence, Treatment
-
Cosenza, Calabria, Italy
- +27 more
Oct 11, 2023
Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)
Active, not recruiting
- Polycythemia Vera
- AOP2014
- +2 more
-
San Giovanni Rotondo, (FG) Puglia, Italy
- +22 more
Jan 10, 2023
Duchenne and Becker Muscular Dystrophy, Polycytemia Vera Trial in Québec (ITF2357 10 mg/mL, Placebo, Moxifloxacin Hydrochloride)
Completed
- Duchenne and Becker Muscular Dystrophy
- Polycytemia Vera
- ITF2357 10 mg/mL
- +2 more
-
Québec, CanadaQuébec
Aug 25, 2021
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Periodontitis Chronic Generalized Severe Trial in Beirut (2.5% flurbiprofen, 98% aloe vera, Placebo)
Completed
- Periodontitis Chronic Generalized Severe
- 2.5% flurbiprofen
- +2 more
-
Beirut, LebanonBeirut Arab University
Sep 11, 2023
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution
Recruiting
- Polycythemia Vera
-
Sohag, EgyptFaculty of Medicine
Aug 12, 2023
Identify and Describe Predictive Factors for Thromboembolic
Not yet recruiting
- Polycythemia Vera
- Hydroxyurea
- Ruxolitinib
- (no location specified)
Nov 2, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +121 more
Oct 21, 2021
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Action of Interferon in Treatment of Myeloproliferative
Recruiting
- Myeloproliferative Neoplasm
-
Villejuif, Ile De France, FranceInserm U1287
Apr 28, 2023
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Pulpitis - Irreversible Trial in Cairo (Pulpotomy)
Completed
- Pulpitis - Irreversible
- Pulpotomy
-
Cairo, EgyptFaculty of Dentistry, Ain Shams University
Dec 7, 2021
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021